Butyrate reduces liver metastasis of rat colon carcinoma cells in vivo and resistance to oxidative stress in vitro

Clinical and Experimental Metastasis

Volumn 21, Issue 4, 2004, Pages 331-338

  Li, Xiaotong ^a   Mikkelsen, Idun M ^a   Mortensen, Bente ^a   Winberg, Jan Olof ^a   Huseby, Nils Erik ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

apoptosis; butyrate; cultured tumor cells; metastatic potential; oxidative stress

Indexed keywords

BUTYRIC ACID; GLUTATHIONE; MENADIONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CARCINOMA CELL; CELL PROLIFERATION; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; INCUBATION TIME; LIVER METASTASIS; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; APOPTOSIS; BUTYRATES; CELL ADHESION; CELL DIVISION; CELL LINE, TUMOR; COLONIC NEOPLASMS; GELATINASES; GLUTATHIONE; LIVER NEOPLASMS, EXPERIMENTAL; MALE; OXIDATIVE STRESS; RATS;

EID: 7244256107     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CLIN.0000046134.80393.34     Document Type: Article

References (43)

1. Hague A, Manning AM, Hanlon KA et al. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer 1993; 55: 498-505.
2. Heerdt BG, Houston MA, Augenlicht LH. Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function. Cell Growth Differ 1997; 8: 523-32.
3. Wu JT, Archer SY, Hinnebusch B et al. Transient vs. prolonged histone hyperacetylation: effect on colon cancer cell growth, differentiation, and apoptosis. Am J Physiol Gastrointest Liver Physiol 2001; 280: G482-90.
4. Augeron C, Laboisse CL. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 1984; 44: 3961-9.
5. Ho SB, Yan PS, Dahiya R et al. Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance. J Cell Physiol 1994; 160: 213-26.
6. Krupitza G, Grill S, Harant H et al. Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells. Br J Cancer 1996; 73: 433-8.
7. Smith TJ, Piscatelli JJ, Andersen V et al. n-Butyrate induces plasminogen activator inhibitor type 1 messenger RNA in cultured Hep G2 cells. Hepatology 1996; 23: 866-71.
8. Emenaker NJ, Basson MD. Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation. J Surg Res 1998; 76: 41-6.
9. Litvak DA, Evers BM, Hwang Ko et al. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1. Surgery 1998; 124: 161-9.
10. Gleave ME, Sato N, Sadar M et al. Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model. J Cell Biochem 1998; 69: 271-81.
11. Yamamoto H, Fujimoto J, Okamoto E et al. Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo. Int J Cancer 1998; 76: 897-902.
12. Miyake H, Hara I, Yamanaka K et al. Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells. Br J Cancer 1999; 79: 1651-6.
13. Wang HH, McIntosh AR, Hasinoff BB et al. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: A natural hepatic defense against metastasis. Cancer Res 2000; 60: 5862-9.
14. Carretero J, Obrador E, Esteve JM et al. Tumoricidal activity of endothelial cells. Inhibition of endothelial nitric oxide production abrogates tumor cytotoxicity induced by hepatic sinusoidal endothelium in response to B16 melanoma adhesion in vitro. J Biol Chem 2001; 276: 25775-82.
15. Pompella A, Visvikis A, Paolicchi A et al. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 2003; 66: 1499-503.
16. Anasagasti MJ, Martin JJ, Mendoza L et al. Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature. Hepatology 1998; 27: 1249-56.
17. Meyer TE, Liang HQ, Buckley AR et al. Changes in glutathione redox cycling and oxidative stress response in the malignant progression of NB2 lymphoma cells. Int J Cancer 1998; 77: 55-63.
18. Carretero J, Obrador E, Anasagasti MJ et al. Growth-associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells. Clin Exp Metast 1999; 17: 567-74.
19. Ortega AL, Carretero J, Obrador E et al. Tumor cytotoxicity by endothelial cells. Impairment of the mitochondrial system for glutathione uptake in mouse B16 melanoma cells that survive after in vitro interaction with the hepatic sinusoidal endothelium. J Biol Chem 2003; 278: 13888-97.
20. Andreassen K, Mortensen B, Winberg JO, Huseby NE. Increased resistance towards oxidative stress accompanies enhancement of metastatic potential obtained by repeated in vivo passage of colon carcinoma cells in syngeneic rats. Clin Exp Metast 2002; 19: 623-9.
21. Marquet RL, Westbroek DL, Jeekel J. Interferon treatment of a transplantable rat colon adenocarcinoma: Importance of tumor site. Int J Cancer 1984; 33: 689-92.
22. Li X, Mortensen B, Rushfeldt C, Huseby NE. Serum gamma- glutamyltransferase and alkaline phosphatase during experimental liver metastases. Detection of tumour-specific isoforms and factors affecting their serum levels. Eur J Cancer 1998; 34: 1935-40.
23. Svendsrud DH, Loennechen T, Winberg JO. Effect of adenosine analogues on the expression of matrix metalloproteinases and their inhibitors from human dermal fibroblasts. Biochem Pharmacol 1997; 53: 1511-20.
24. Winberg JO, Kolset SO, Berg E, Uhlin-Hansen L. Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans. J Mol Biol 2000; 304: 669-80.
25. Loennechen T, Mathisen B, Hansen J et al. Colchicine induces membrane-associated activation of matrix metalloproteinase-2 in osteosarcoma cells in an S100A4-independent manner. Biochem Pharmacol 2003; 66: 2341-53.
26. Mathisen B, Lindstad RI, Hansen J et al. S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells. Clin Exp Metast 2003; 20: 701-11.
27. Hattori S, Fujisaki H, Kiriyama T et al. Real-time zymography and reverse zymography: A method for detecting activities of matrix metalloproteinases and their inhibitors using FITC-labelled collagen and casein as substrates. Anal Biochem 2002; 301: 27-34.
28. Winberg JO, Gedde-Dahl T. Gelatinase expression in generalized epidermolysis bullosa simplex fibroblasts. J Invest Dermatol 1986; 87: 326-9.
29. Marks PA, Rifkind RA, Richon VM et al. Histone deacetylases and cancer: Causes and therapies. Nature Reviews Cancer 2001; 1: 194-202.
30. Archer SY, Meng S, Shei A, Hodin RA. p21 (WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 1998; 95: 6791-6.
31. Hara I, Miyake H, Hara S et al. Sodium butyrate induced apoptosis in human renal cell carcinoma cells and synergistically enhances their sensitivity to anti-fas-mediated cytotoxicity. Int J Oncol 2000; 17: 1213-8.
32. Levy P, Robin H, Bertrand F et al. Butyrate-treated colonic Caco-2 cells exhibit defective integrin-mediated signaling together with increased apoptosis and differentiation. J Cell Physiol 2003; 197: 336-47.
33. Benard O, Balasubramanian KA. Modulation of glutathione level during butyrate-induced differentiation in human colon derived HT-29 cells. Mol Cell Biochem 1997; 170: 109-1.
34. Giardina C, Inan MS. Nonsteroidal anti-inflammatory drugs, short-chain fatty acids, and reactive oxygen metabolism in human colorectal cancer cells. Biochim Biophys Acta 1998; 1401: 277-88.
35. Mikkelsen IM, Mortensen B, Laperche Y, Huseby NE. The expression of gamma-glutamyltransferase in rat colon carcinoma cells is distinctly regulated during differentiation and oxidative stress. Mol Cell Biochem 2002; 232: 87-95.
36. Velazquez OC, Jabbar A, DeMatteo RP, Rombeau JL. Butyrate inhibits seeding and growth of colorectal metastases to the liver in mice. Surgery 1996; 120: 440-7.
37. Cornelius LA, Nehring LC, Harding E et al. Matrix metalloproteinases generate angiostatin: effect on neovascularization. J Immunol 1998; 161: 6845-52.
38. Sang QX. Complex role of matrix metalloproteinases in angiogenesis. Cell Res 1998; 8: 171-7.
39. Yang JQ, Zhao W, Duan H et al. V-Ha-Ras oncogene upregulates the 92-kDa type IV collagenase (MMP-9) gene by increasing cellular superoxide production and activating NF-κB. Free Rad Biol Med 2001; 31: 520-9.
40. 2 activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phoshatidylinositol 3-kinase/NF-κB pathway. J Biol Chem 2002; 277: 30271-82.
41. Wilson JR, Weiser MM. Colonic cancer cell (HT29) adhesion to laminin is altered by differentiation: Adhesion may involve galactosyltransferase. Exp Cell Res 1992; 201: 330-4.
42. 1 integrin: A possible role in the induction of apoptosis in colorectal cancer cell lines. Gut 2003; 52: 729-34.
43. Murphy G, Crabbe T. Gelatinases A and B. Meth Enzymol 1995; 248: 470-84.